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ABSTRACTSyear survival estimates, but follow up limits comparison of actual survival.
However, a recent study has suggested that 2 year follow up data corre-
lates well with 5-year survival.
0486: "SATURATION PROSTATE BIOPSY IN PATIENTS WITH RAISED AGE-
RELATED PSA AND NON-MALIGNANT PREVIOUS TRUS BIOPSIES"
Michelle Christodoulidou, Mohsen El-Gammal. Southport and Ormskirk
Hospital NHS Trust, Southport,Merseyside, UK
Aim: To review the demographic data of patients that underwent Satu-
ration Prostate Biopsies over an 18 month period with emphasis on the
indications, antibiotic cover, complications and histological outcome.
Method: Patients were traced by the Theatres Register and GALAXY
system. Data were collected from case notes.
Results: 28 Saturation Biopsies were performed between July 2010 and
December 2011. Median age was 67, 54% of patients had LUTS and 7% had
family history of prostate cancer. 14% had abnormal DRE. Median value of 2
TRUS biopsies were taken prior to the Saturation Biopsy. All patients were
given 160mg Gentamicin IV and a 3 day course of Ciproﬂoxacin orally. Only
one case presentedwith Urosepsis requiring IV antibiotics. Saturation biopsy
diagnosedmalignancy in36%ofpatients.1patientwhohadbenign saturation
biopsy subsequently underwent a Template biopsy that showedmalignancy.
Conclusions: Saturation Biopsy is useful in diagnosing prostate cancer in
about 36% of cases after 2 inconclusive TRUS Biopsies. The pick up rate of
cancer is higher than a 3rd TRUS biopsy. The currently adopted antibiotic
prophylaxis appears appropriate with 3.6% risk of urosepsis. When Satu-
ration Biopsy is non malignant and PSA is still rising, template biopsy
maybe considered.
0524: USE OF THE SWOP CALCULATOR TO REDUCE UNNECESSARY
PROSTATE BIOPSIES IN MEN WITH ELEVATED PSA
Andrew Birch 1, John Withington 1, Janette Kinsella 2, Peter Acher 1, Ben
Challacombe 2. 1 East Sussex Healthcare NHS Trust, East Sussex, UK; 2Guy's
and St. Thomas' NHS Foundation Trust, London, UK
Background: The SWOP calculator is a nomogram derived from the Euro-
pean Randomised Study of Screening for Prostate Cancer which predicts the
percentage probability ofmalignant prostate biopsy by using the variables of
age, DRE ﬁnding, PSA, ultrasound appearance and prostate volume.
Aim: To investigate whether using a 10% or 15% risk threshold could avert
unnecessary biopsies.
Method: Data from 207 eligible patients (median age 60) biopsied from
2004-2010 were entered retrospectively into the risk calculator. The clin-
ical outcomes for patients with 15% SWOP risk were investigated.
Results: Of the 42 patients with 15% SWOP risk 13 patients (31%) had
malignant histology at biopsy (9 Gleason 3+3, 4 Gleason 3+4), 7 received
radical treatment (5 radical prostatectomies, 2 brachytherapy) and 5
entered active surveillance.
Of the 17 patients with a SWOP risk 10% 4 (24%) had positive biopsies
(Gleason 3+3); none required treatment, 3 entered active surveillance (one
patient has no follow-up data).
Conclusions: These data show that were a 15% risk threshold applied, then
signiﬁcant prostate cancers requiring treatment would have been missed
but a 10% risk-threshold may have avoided unnecessary biopsies.
The SWOP calculator may be useful for avoiding unnecessary biopsies in
low-risk patients; this has signiﬁcant implications for reducing biopsy and
treatment morbidity and cost.
0551: TRANSPERINEAL TEMPLATE-GUIDED SATURATION BIOPSIES OF
THE PROSTATE – EARLY EXPERIENCES IN A DISTRICT GENERAL
HOSPITAL OF A NOVEL TECHNIQUE OF SATURATION BIOPSY
Jaspal Phull, Alison Townsend, Megan Whitaker, Llinos Davies, Andy
Thomas. Princess of Wales Hospital, Bridgend, UK
Aims: Transrectal ultrasound-guided (TRUS) biopsy may miss 30% of
signiﬁcant prostate cancer, likely to be in the anterior zone. Transperineal
template-guided saturation biopsies (TTB) is a NICE approved means of
saturation-biopsy. We assessed detection rates with TTB.
Methods: A prospective, non-randomized, cohort study of TTBs between
July 2010 and August 2011. All cases were peer-reviewed at MDT, and
would seek radical treatment if positive.
The primary outcome was detection of malignancy.Results: 22 TTBs were performed. 81.8% (n¼18) had >1 negative TRUS, 9.1%
(n¼2) were on active surveillance, 4.5% (n¼1) was post-radiotherapy PSA-
relapse, and 4.5% (n¼1) chose to have TTB as the primary biopsy method.
12 of the 22 cases (54.5%) had new-diagnosis carcinoma only detected at
TTB. 7 were benign (31.8%).
Of the malignant histology (n¼15) 13.3% were Gleason 6 (n¼2), 73.3% were
Gleason 7 (n¼11), and 13.3% were Gleason 8 carcinomas (n¼2).
Conclusion: TTB should be considered for men with rising PSAs and
negative TRUS biopsy. We advocate TTB as the preferred technique for
saturation biopsy for detection of signiﬁcant prostate cancer in men who
would beneﬁt from further treatment.
0572: OUT-PATIENT FLEXIBLE CYSTOSCOPY CAUSES PSYCHOLOGICAL
DISTRESS TO A SIGNIFICANT NUMBER OF PATIENTS BEING
INVESTIGATED FOR BLADDER CANCER
Gidon Ellis 1, Jamie Fairweather 1, Ninaad Awsare 2, Sam Osaghae 3, Sam
Smith 4, Thomas McNicholas 5, James Green 1. 1Whipps Cross University
Hosptial, London, UK; 2Morriston Hospital, Swansea, UK; 3 Pilgrim Hospital,
Lincolnshire, UK; 4University College London, London, UK; 5 Lister Hospital,
Stevenage, UK
Introduction: Many patients undergoing outpatient ﬂexible cystoscopy
experience psychological distress. This may relate to the impending
procedure and to the possibility of discovering cancer. We set out to
investigate the prevalence of signiﬁcant psychological distress in a cohort
of patients undergoing ﬂexible cystoscopy and to identify subsets of the
population who may be at higher risk.
Methods: We recruited 173 patients undergoing out-patient ﬂexible
cystoscopywho completed questionnaires containing the Hospital Anxiety
and Depression Score-A (HADS) and HADS-D to assess anxiety and
depression respectively. A score of 11/21 on either scale was regarded as
clinically signiﬁcant.
Results: The overall prevalence of anxiety was 15%, which was higher in
females (p¼0.025), in the young (p¼0.001) and in unmarried individuals
(p¼ 0.02). The prevalence of depressionwas 3.5%, which was higher in the
young (0.001) and in unmarried individuals (p¼0.02).
Conclusion: The prevalence of clinically signiﬁcant anxiety and depression
in this cohort is notable; in particular amongst women, younger and
unmarried patients. Accelerating the diagnostic pathway, improving
patient information and offering counselling to those affected may help to
reduce distress. Resources could be targeted at the higher risk groups
identiﬁed here. The HADS questionnaires are a useful ﬁrst-line screening
tool for psychological distress.
0605: SMALL SIZE NEPHROSTOMY TUBE USE POST PCNL
Ben Rossi, Michal Sut, Asheesh Kaul, Abdul Rahim Khan, Aasem
Chaudry. Bedford Hospital NHS Trust, Bedford, UK
Objective: To assess safety and outcomes of a small size 8F/8.5F neph-
rostomy tube use following Percutaneous Nephrolithotomy.
Materials and methods: Retrospective data collection from 15 PCNL cases
performed in Bedford Hospital NHS Trust over a period of 10months. Stone
clearance, hospital stay, complication rate, hemoglobin drop, analgesia and
transfusion requirements were reviewed. Data was compared to recently
published outcomes for tubeless PCNL and large bore nephrostomy use.
Results: Median hemoglobin drop was 1.3 g.dL and length of stay was 72
hours. Those were comparable to previously reported results for tubeless
PCNLand large borenephrostomy tubeuse. Complication ratewas lowat 13%
with only one patient requiring admission and treatment for urinary sepsis
and one patient requiring repeat procedure due to pain related to residual
stone. Stone clearance on day 1was 60%. Average analgesia requirementwas
1050mg of tramadol which was signiﬁcantly higher than in previously re-
ported studies and was likely related to our prescribing protocol.
Conclusions: Small size nephrostomy PCNL is a safe procedure with
acceptable Hb drop and length of stay. Decreased analgesia requirements
proven previously were not reproduced in our group of patients.
0622: UROLOGY CANCER PATIENTS' VIEWS ON MULTIDISCIPLINARY
TEAM (MDT) WORKING. A PILOT STUDY
Benjamin Lamb 1, Rozh Jalil 1, Sujay Shah 1, James Green 2, Paula
Allchorne 2, Nick Sevdalis 1. 1 Imperial College, London, UK; 2Whipps Cross
University Hospital, London, UK
